Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/81423
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | The effect of exogenous glucose-dependent insulinotropic polypeptide in combination with glucagon-like peptide-1 on glycemia in the critically ill |
Author: | Lee, M. Fraser, J. Chapman, M. Sundararajan, K. Umapathysivam, M. Summers, M. Zaknic, A. Rayner, C. Meier, J. Horowitz, M. Deane, A. |
Citation: | Diabetes Care, 2013; 36(10):3333-3336 |
Publisher: | Amer Diabetes Assoc |
Issue Date: | 2013 |
ISSN: | 0149-5992 1935-5548 |
Statement of Responsibility: | Michael Y. Lee, Jonathan D. Fraser, Marianne J. Chapman, Krishnaswamy Sundararajan, Mahesh M. Umapathysivam, Matthew J. Summers, Antony V. Zaknic, Christopher K. Rayner, Juris J. Meier, Michael Horowitz, Adam M. Deane |
Abstract: | OBJECTIVE Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) have additive insulinotropic effects when coadministered in health. We aimed to determine whether GIP confers additional glucose lowering to that of GLP-1 in the critically ill. RESEARCH DESIGN AND METHODS Twenty mechanically ventilated critically ill patients without known diabetes were studied in a prospective, randomized, double-blind, crossover fashion on 2 consecutive days. Between T₀ and T₄₂₀ minutes, GLP-1 (1.2 pmol/kg • min−1) was infused intravenously with either GIP (2 pmol/kg • min⁻¹) or 0.9% saline. Between T₆₀ and T₄₂₀ minutes, nutrient liquid was infused into the small intestine at 1.5 kcal/min. RESULTS Adding GIP did not alter blood glucose or insulin responses to small intestinal nutrient. GIP increased glucagon concentrations slightly before nutrient delivery (P = 0.03), but not thereafter. CONCLUSIONS The addition of GIP to GLP-1 does not result in additional glucose-lowering or insulinotropic effects in critically ill patients with acute-onset hyperglycemia. |
Keywords: | Humans Hyperglycemia Critical Illness Gastric Inhibitory Polypeptide Blood Glucose Prospective Studies Cross-Over Studies Double-Blind Method Adult Aged Middle Aged Female Male Glucagon-Like Peptide 1 |
Rights: | © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
DOI: | 10.2337/dc13-0307 |
Published version: | http://dx.doi.org/10.2337/dc13-0307 |
Appears in Collections: | Aurora harvest Medicine publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_81423.pdf | Published version | 317.28 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.